Oxfam urges cancellation of Pfizer’s patent on hypertension drug
MANILA, Philippines — International agency, Oxfam urges the Intellectual Property Office
(IPO) to cancel the patent of Pfizer on anti-hypertension drug,
Norvasc in the Philippines following the recent decision of the US
Court of Appeals nullifying the patent granted to Pfizer for
amlodipine besylate, Norvasc’s active ingredient.
(more…)
